Φορτώνει......
Left ventricular dysfunction in an idiopathic pulmonary fibrosis patient on nintedanib
Nintedanib, a tyrosine kinase inhibitor, is approved for the treatment of idiopathic pulmonary fibrosis. We report a case of left ventricular dysfunction in a patient with idiopathic pulmonary fibrosis treated with nintedanib, which recovered after cessation of nintedanib. Nintedanib may induce left...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Respirol Case Rep |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley & Sons, Ltd
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7017142/ https://ncbi.nlm.nih.gov/pubmed/32082576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.533 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|